10:00 AM EDT, 04/01/2025 (MT Newswires) -- Aptose Biosciences ( APTO ) said Tuesday the Nasdaq Hearings Panel has decided to delist its shares from the stock exchange on Wednesday due to the company's failure to comply with the equity requirement for continued listing.

The company said it was unable to regain compliance by March 31.

Aptose said it will review "all available options, including an appeal to the determination" and will apply to list on a US national securities exchange "at the appropriate time."

The company's shares were falling more than 51% in recent trading.

Price: 1.54, Change: -1.63, Percent Change: -51.41